Alyeska Investment Group, L.P. Concert Pharmaceuticals, Inc. Transaction History

Alyeska Investment Group, L.P.

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$4.34 - $5.84 $167,432 - $225,301	38,579 Added 7.72%	538,579 $3.15 Million
Q3 2022 Nov 14, 2022	SELL	$4.27 - $7.2 $426,999 - $720,000	-100,000 Reduced 16.67%	500,000 $3.35 Million
Q2 2022 Aug 15, 2022	BUY	$2.8 - $6.36 $145,348 - $330,147	51,910 Added 9.47%	600,000 $2.53 Million
Q4 2021 Feb 14, 2022	BUY	$2.69 - $4.22 $134,500 - $211,000	50,000 Added 10.04%	548,090 $1.73 Million
Q2 2021 Aug 16, 2021	BUY	$3.77 - $5.24 $568,783 - $790,564	150,871 Added 43.45%	498,090 $2.1 Million
Q4 2020 Feb 16, 2021	SELL	$9.48 - $12.84 $1.83 Million - $2.48 Million	-193,135 Reduced 35.74%	347,219 $4.39 Million
Q3 2020 Nov 16, 2020	BUY	$8.67 - $10.82 $325,740 - $406,518	37,571 Added 7.47%	540,354 $5.31 Million
Q2 2020 Aug 14, 2020	BUY	$7.8 - $11.52 $396,887 - $586,172	50,883 Added 11.26%	502,783 $5 Million
Q1 2020 May 15, 2020	BUY	$5.98 - $13.09 $796,906 - $1.74 Million	133,262 Added 41.82%	451,900 $3.99 Million
Q4 2019 Feb 14, 2020	BUY	$5.71 - $9.22 $62,239 - $100,498	10,900 Added 3.54%	318,638 $2.94 Million
Q2 2019 Aug 14, 2019	BUY	$9.44 - $13.12 $881,403 - $1.23 Million	93,369 Added 43.56%	307,738 $0
Q1 2019 May 15, 2019	BUY	$12.07 - $17.54 $1.44 Million - $2.09 Million	119,369 Added 125.65%	214,369 $0
Q4 2018 Feb 14, 2019	SELL	$11.25 - $16.17 $3.07 Million - $4.42 Million	-273,243 Reduced 74.2%	95,000 $1.19 Million
Q3 2017 Nov 14, 2017	BUY	$13.91 - $15.31 $5.12 Million - $5.64 Million	368,243	368,243 $5.43 Million

Ticker CNCE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,934,600
Description
Concert Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company that develops novel small molecule drugs for the treatment of autoimmune diseases. The company's lead product candidate is CTP-543, which is in Phase III clinical trial for the treatment of alopecia areata, a serious autoimmune dermatological condition. It has s...

Get notified when there are updates to the investment portfolio of Alyeska Investment Group, L.P., based on Form 13F filings with the SEC.

Stay updated on Alyeska Investment Group, L.P. with notifications on news.